On statistical evaluation for interchangeability of biosimilar products
Author byline as per print journal: Yuqi Li, BS Pharm; Shein-Chung Chow, PhD Abstract: A biosimilar product is a biological product which is highly similar to an existing reference product in structure and function and has no clinically meaningful difference in terms of safety, purity or potency. Under the Biologics Price Competition and Innovation Act of […]
